# Study Evaluating The Excretion Of Moxidectin Into The Breast Milk Of Lactating, Non-Breastfeeding Women

> **NCT00751764** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 12 (estimated)

## Conditions studied

- Infection

## Interventions

- **DRUG:** Moxidectin

## Key facts

- **NCT ID:** NCT00751764
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2010-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00751764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00751764, "Study Evaluating The Excretion Of Moxidectin Into The Breast Milk Of Lactating, Non-Breastfeeding Women". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00751764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*